On the public citation graph
Metal-Dependent Cytotoxic and Kinesin Spindle Protein Inhibitory Activity of Ru, Os, Rh, and Ir Half-Sandwich Complexes of Ispinesib-Derived Ligands
0 signed · 89 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/9780470132609.ch53openalex-snapshot
(η 5 ‐Pentamethylcyclopentadienyl)Rhodium and ‐Iridium Compounds
inferredcites →https://doi.org/10.1002/chem.201202657openalex-snapshot
Am(m)ines Make the Difference: Organoruthenium Am(m)ine Complexes and Their Chemistry in Anticancer Drug Development
inferredcites →https://doi.org/10.1002/chem.201601809openalex-snapshot
Ferrocenyl Paclitaxel and Docetaxel Derivatives: Impact of an Organometallic Moiety on the Mode of Action of Taxanes
inferredcites →https://doi.org/10.1002/chin.201606268openalex-snapshot
ChemInform Abstract: Ferrocifen Type Anticancer Drugs
inferredcites →https://doi.org/10.1002/cmdc.201000063openalex-snapshot
Azides Derived from Colchicine and their Use in Library Synthesis: a Practical Entry to New Bioactive Derivatives of an Old Natural Drug
inferredcites →https://doi.org/10.1002/cmdc.201700576openalex-snapshot
Synthesis and in vitro Biological Evaluation of Ferrocenyl Side‐Chain‐Functionalized Paclitaxel Derivatives
inferredcites →https://doi.org/10.1002/pbc.22056openalex-snapshot
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program
inferredcites →https://doi.org/10.1007/978-3-642-13185-1_2openalex-snapshot
Activation Mechanisms for Organometallic Anticancer Complexes
inferredcites →https://doi.org/10.1007/s00044-014-1120-zopenalex-snapshot
Synthesis, docking studies, and in silico ADMET predictions of some new derivatives of pyrimidine as potential KSP inhibitors
inferredcites →https://doi.org/10.1007/s10637-011-9653-1openalex-snapshot
A phase I trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors
inferredcites →https://doi.org/10.1016/0006-2952(86)90608-8openalex-snapshot
Cellular and molecular pharmacology of auranofin and related gold complexes
inferredcites →https://doi.org/10.1016/0022-328x(90)85149-sopenalex-snapshot
Carbonyl-η-hexamethylbenzene complexes of osmium. Carbon-hydrogen activation by (η-C6Me6)Os(CO)(H)2
inferredcites →https://doi.org/10.1016/j.bbcan.2007.10.004openalex-snapshot
Taxanes, microtubules and chemoresistant breast cancer
inferredcites →https://doi.org/10.1016/j.bbrc.2008.05.074openalex-snapshot
Crystal structure of HsEg5 in complex with clinical candidate CK0238273 provides insight into inhibitory mechanism, potency, and specificity
inferredcites →https://doi.org/10.1016/j.bcp.2013.07.010openalex-snapshot
Antimitotic drugs in cancer chemotherapy: Promises and pitfalls
inferredcites →https://doi.org/10.1016/j.bmc.2012.11.013openalex-snapshot
Fluorinated quinazolinones as potential radiotracers for imaging kinesin spindle protein expression
inferredcites →https://doi.org/10.1016/j.ccr.2019.07.008openalex-snapshot
Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure
inferredcites →https://doi.org/10.1016/j.cub.2006.12.037openalex-snapshot
BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
inferredcites →https://doi.org/10.1016/j.drudis.2014.06.016openalex-snapshot
Development of anticancer agents: wizardry with osmium
inferredcites →https://doi.org/10.1016/j.ejmech.2013.01.031openalex-snapshot
Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents
inferredcites →https://doi.org/10.1016/j.ica.2012.06.046openalex-snapshot
Rhodium(III) and iridium(III) complexes as anticancer agents
inferredcites →https://doi.org/10.1016/j.jinorgbio.2010.10.004openalex-snapshot
From hydrolytically labile to hydrolytically stable RuII–arene anticancer complexes with carbohydrate-derived co-ligands
inferredcites →https://doi.org/10.1016/j.jorganchem.2017.02.005openalex-snapshot
Approach to ferrocenyl-podophyllotoxin analogs and their evaluation as anti-tumor agents
inferredcites →https://doi.org/10.1016/j.oraloncology.2014.06.014openalex-snapshot
Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): A systematic review
inferredcites →https://doi.org/10.1016/j.tranon.2016.10.003openalex-snapshot
PLK1, A Potential Target for Cancer Therapy
inferredcites →https://doi.org/10.1016/j.vascn.2016.11.001openalex-snapshot
Drug-selected cell line panels for evaluation of the pharmacokinetic consequences of multidrug resistance proteins
inferredcites →https://doi.org/10.1016/s0021-9258(20)80702-9openalex-snapshot
Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance.
inferredcites →https://doi.org/10.1016/s0891-5849(98)00315-3openalex-snapshot
Antioxidant activity applying an improved ABTS radical cation decolorization assay
inferredcites →https://doi.org/10.1021/acs.organomet.5b00868openalex-snapshot
Impact of the Halogen Substitution Pattern on the Biological Activity of Organoruthenium 8-Hydroxyquinoline Anticancer Agents
inferredcites →https://doi.org/10.1021/acsmedchemlett.6b00046openalex-snapshot
Ferrocenyl 2,5-Piperazinediones as Tubulin-Binding Organometallic ABCB1 and ABCG2 Inhibitors Active against MDR Cells
inferredcites →https://doi.org/10.1021/cr100147uopenalex-snapshot
Natural Taxanes: Developments Since 1828
inferredcites →https://doi.org/10.1021/jm401708fopenalex-snapshot
Silicate Esters of Paclitaxel and Docetaxel: Synthesis, Hydrophobicity, Hydrolytic Stability, Cytotoxicity, and Prodrug Potential
inferredcites →https://doi.org/10.1021/ml5001883openalex-snapshot
Development of a New Benzophenone–Diketopiperazine-Type Potent Antimicrotubule Agent Possessing a 2-Pyridine Structure
inferredcites →https://doi.org/10.1038/nrc1502openalex-snapshot
Aurora-kinase inhibitors as anticancer agents
inferredcites →https://doi.org/10.1038/s41598-017-05464-0openalex-snapshot
Efficacy and safety of taxane-based systemic chemotherapy of advanced gastric cancer: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1038/s41598-017-14754-6openalex-snapshot
Structural basis of small molecule ATPase inhibition of a human mitotic kinesin motor protein
inferredcites →https://doi.org/10.1039/c2dt32206dopenalex-snapshot
3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure–activity relationships and stability studies on Ru II (arene) anticancer complexes with biologically active ligands
inferredcites →https://doi.org/10.1039/c2md00315eopenalex-snapshot
Synthesis and biological activities of ferrocenyl derivatives of paclitaxel
inferredcites →https://doi.org/10.1039/c7cs00332copenalex-snapshot
Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development
inferredcites →https://doi.org/10.1039/c7dt02107kopenalex-snapshot
Synthesis and evaluation of biological properties of ferrocenyl–podophyllotoxin conjugates
inferredcites →https://doi.org/10.1039/c7dt03229copenalex-snapshot
Colchicine metallocenyl bioconjugates showing high antiproliferative activities against cancer cell lines
inferredcites →https://doi.org/10.1039/c8dt90016gopenalex-snapshot
Correction: Colchicine metallocenyl bioconjugates showing high antiproliferative activities against cancer cell lines
inferredcites →https://doi.org/10.1039/c8nj01681jopenalex-snapshot
Structural and solution equilibrium studies on half-sandwich organorhodium complexes of (N,N) donor bidentate ligands
inferredcites →https://doi.org/10.1039/dt9740000233openalex-snapshot
Arene ruthenium(II) complexes formed by dehydrogenation of cyclohexadienes with ruthenium(III) trichloride
inferredcites →https://doi.org/10.1080/00958972.2013.857016openalex-snapshot
Synthesis, crystal structure, fluorescence, electrochemical property, and SOD-like activity of an unexpected nickel(II) complex with a quinazoline-type ligand
inferredcites →https://doi.org/10.1080/00958972.2017.1334259openalex-snapshot
Synthesis, X-ray structure,in vitroHIV and kinesin Eg5 inhibition activities of new arene ruthenium complexes of pyrimidine analogs
inferredcites →https://doi.org/10.1080/10426507.2019.1597362openalex-snapshot
A ruthenium complexes of monastrol and its pyrimidine analogues: Synthesis and biological properties
inferredcites →https://doi.org/10.1083/jcb.201808077openalex-snapshot
Anti-mitotic therapies in cancer
inferredcites →https://doi.org/10.1089/ars.2009.2876openalex-snapshot
Superoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic Potential
inferredcites →https://doi.org/10.1097/01.cad.0000182745.01612.8aopenalex-snapshot
NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent
inferredcites →https://doi.org/10.1107/s0907444912027965openalex-snapshot
The structure of the ternary Eg5–ADP–ispinesib complex
inferredcites →https://doi.org/10.1126/science.286.5441.971openalex-snapshot
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-1498openalex-snapshot
Activity of the Kinesin Spindle Protein Inhibitor Ispinesib (SB-715992) in Models of Breast Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-13-2506openalex-snapshot
Phase I Study of Oral Rigosertib (ON 01910.Na), a Dual Inhibitor of the PI3K and Plk1 Pathways, in Adult Patients with Advanced Solid Malignancies
inferredcites →https://doi.org/10.1182/blood.v108.11.4401.4401openalex-snapshot
ARRY-429520, a Novel KSP Inhibitor with Potent Anti-Proliferative Activity in Leukemic Cell Lines.
inferredcites →https://doi.org/10.1517/13543776.18.3.253openalex-snapshot
Therapeutic potential of mitotic kinesin inhibitors in cancer
inferredcites →https://doi.org/10.1517/13543784.15.11.1411openalex-snapshot
Development of new cancer therapeutic agents targeting mitosis
inferredcites →https://doi.org/10.18632/oncotarget.14893openalex-snapshot
Aurora kinases: novel therapy targets in cancers
inferredcites →https://doi.org/10.2174/092986709789352277openalex-snapshot
Medicinal Chemistry of Paclitaxel and its Analogues
inferredcites →https://doi.org/10.2174/156800907783220499openalex-snapshot
Novel Mitotic Targets and Their Small-Molecule Inhibitors
inferredcites →https://doi.org/10.3109/10428194.2015.1020058openalex-snapshot
The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity inin vivoandin vitromodels of aggressive large B-cell lymphoma
inferredcites →https://doi.org/10.3389/fonc.2015.00278openalex-snapshot
Aurora Kinase Inhibitors: Current Status and Outlook
inferredcites →https://doi.org/10.3747/co.21.1997openalex-snapshot
Update on Taxanes in the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
inferredcites →https://doi.org/10.3987/com-10-s(e)117openalex-snapshot
A Convenient Entry to New C-7-Modified Colchicinoids through Azide Alkyne [3+2] Cycloaddition: Application of Ring-Contractive Rearrangements
inferredcites →https://doi.org/10.4155/fmc.16.5openalex-snapshot
Recent Findings and Future Directions for Interpolar Mitotic Kinesin Inhibitors in Cancer Therapy
inferredcites →https://doi.org/10.6061/clinics/2018/e813sopenalex-snapshot
Natural products as new antimitotic compounds for anticancer drug development
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4121949openalex-extracted
Preparation of novel Rh (III) half-sandwich complexes bearing 5-phenyl-2-(pyridin-2-yl)-1,2-dihydro-3H-pyrazol-3-one ligands, and their anti-cancer properties
inferred← citeshttps://doi.org/10.1002/chem.202300813openalex-snapshot
Design, Synthesis, and Evaluation of Biological Activity of Ferrocene‐Ispinesib Hybrids: Impact of a Ferrocenyl Group on the Antiproliferative and Kinesin Spindle Protein Inhibitory Activity
inferred← citeshttps://doi.org/10.1002/cjoc.202100901openalex-snapshot
A Rhein‐Based Rh( III ) Arene Complex with Anti‐tumor Cell Proliferative Activity Inhibits RNA Demethylase FTO
inferred← citeshttps://doi.org/10.1016/b978-0-12-820206-7.00045-7openalex-snapshot
Organometallic Chemistry of Anticancer Ruthenium and Osmium Complexes
inferred← citeshttps://doi.org/10.1016/j.bcp.2024.116229openalex-snapshot
Cancer on motors: How kinesins drive prostate cancer progression?
inferred← citeshttps://doi.org/10.1016/j.ccr.2021.213950openalex-snapshot
Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands
inferred← citeshttps://doi.org/10.1016/j.ccr.2021.213999openalex-snapshot
The interaction of rhodium compounds with proteins: A structural overview
inferred← citeshttps://doi.org/10.1016/j.mcat.2021.112050openalex-snapshot
Theoretical investigation of mechanism and ligand effects on half-sandwich iridium complexes for direct reductive amination
inferred← citeshttps://doi.org/10.1021/acs.inorgchem.2c03279openalex-snapshot
Increasing Anticancer Activity with Phosphine Ligation in Zwitterionic Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c01147openalex-snapshot
Ruthenocenyl and 1-Adamantyl Paclitaxel Analogs Disrupt the Balance between βIII- and βIVa-Tubulin and Inhibit the Growth and Invasiveness of Colon Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c01956openalex-snapshot
Ferrocene–Diiron(I) Bis(cyclopentadienyl) Conjugates Exhibit Potent In Vitro Cytotoxicity and Selectivity toward Cancer Cells Associated with ROS Scavenging
inferred← citeshttps://doi.org/10.1021/acsomega.3c10482openalex-snapshot
Development of Half-Sandwich Ru, Os, Rh, and Ir Complexes Bearing the Pyridine-2-ylmethanimine Bidentate Ligand Derived from 7-Chloroquinazolin-4(3H)-one with Enhanced Antiproliferative Activity
inferred← citeshttps://doi.org/10.1039/d1dt03553copenalex-snapshot
Impact of the ferrocenyl group on cytotoxicity and KSP inhibitory activity of ferrocenyl monastrol conjugates
inferred← citeshttps://doi.org/10.1039/d2dt01929aopenalex-snapshot
Cell nucleus localization and high anticancer activity of quinoline–benzopyran rhodium( iii ) metal complexes as therapeutic and fluorescence imaging agents
inferred← citeshttps://doi.org/10.1039/d3dt01217dopenalex-snapshot
Organometallic Ru, Os, Rh and Ir half-sandwich conjugates of ispinesib – impact of the organometallic group on the antimitotic activity
inferred← citeshttps://doi.org/10.1039/d4dt01853bopenalex-snapshot
Design and synthesis of ferrocenyl 1,4-dihydropyridines and their evaluation as kinesin-5 inhibitors
inferred← citeshttps://doi.org/10.1039/d4dt03219eopenalex-snapshot
A comprehensive survey of cytotoxic active half-sandwich Ir( iii ) complexes: structural perspective, and mechanism of action
inferred← citeshttps://doi.org/10.1039/d4qi02472aopenalex-snapshot
Anticancer iridium( iii ) cyclopentadienyl complexes
inferred← citeshttps://doi.org/10.2144/fsoa-2021-0116openalex-snapshot
Kinesin Spindle Protein Inhibitors in Cancer: From High Throughput Screening to Novel Therapeutic Strategies
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.